P16INK4a protein expression is associated with poor survival of the breast cancer patients after CMF chemotherapy. (Q43862141)

From Wikidata
Jump to navigation Jump to search
scientific article published in December 2001
edit
Language Label Description Also known as
English
P16INK4a protein expression is associated with poor survival of the breast cancer patients after CMF chemotherapy.
scientific article published in December 2001

    Statements

    P16INK4a protein expression is associated with poor survival of the breast cancer patients after CMF chemotherapy (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit